Form 4: Tanger Director Jeffrey Citrin Acquires Deferred Shares
Insider Transaction Report
Tanger Inc. Director Jeffrey B. Citrin acquired 517.45 deferred share units at $33.82 each, increasing his beneficial ownership to 150,094.67 units, as part of a pre-arranged plan.
Summary
- Jeffrey B. Citrin, a Director of Tanger Inc. (SKT), acquired 517.45 deferred share units.
- The acquisition occurred on 11/14/2025 at a price of $33.82 per unit.
- These deferred share units are equivalent to common shares and become payable upon termination of his service as a director.
- His total beneficial ownership after this transaction is 150,094.67 deferred share units.
- An additional 95.25 deferred share units were acquired through a dividend reinvestment program since the last Form 4 filing.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged purchase or sale.
Sentiment
Score: 7
Explanation: The acquisition of additional deferred share units by a director, especially under a pre-arranged plan and through dividend reinvestment, generally signals confidence in the company's long-term value. While not a direct open-market purchase, it aligns insider interests with shareholders.
Positives
- Director Jeffrey B. Citrin increased his beneficial ownership in Tanger Inc. through the acquisition of 517.45 deferred share units.
- The acquisition was part of a pre-arranged Rule 10b5-1(c) plan, suggesting a structured approach to insider transactions.
- Additional 95.25 deferred share units were acquired via dividend reinvestment, indicating continued participation in the company's equity programs.
Future Outlook
The filing indicates a planned future transaction on November 14, 2025, under a Rule 10b5-1 plan, suggesting a pre-determined strategy for the director's equity holdings.
Industry Context
Insider transactions, particularly acquisitions by directors, are often viewed by the market as a signal of confidence in the company's future prospects. The use of deferred share units as compensation is a common practice in the real estate investment trust (REIT) sector, aligning director interests with long-term shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation Program | The Director Deferred Share Program allows directors to acquire deferred share units, which are equivalent to common shares and become payable upon termination of service. | N/A | Aligns director incentives with long-term shareholder value by deferring equity compensation until service termination. |
Related Party Transactions
- The acquisition of deferred share units by Director Jeffrey B. Citrin is a related party transaction as it involves an insider and the company's equity compensation program.
Stakeholder Impact
- Shareholders: The director's increased beneficial ownership may be viewed positively as it aligns his interests with those of other shareholders, potentially signaling confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 11/14/2025 | Transaction Date for the acquisition of 517.45 deferred share units. |
| 11/17/2025 | Signature date of the reporting person's attorney-in-fact for the Form 4 filing. |
Recommendation
holdWhile the director's acquisition of deferred share units and participation in dividend reinvestment signals confidence, these are part of a compensation program and a pre-arranged plan (10b5-1). This type of insider activity, while positive, is less indicative of immediate market-moving conviction compared to large, discretionary open-market purchases. Therefore, it supports a 'hold' recommendation, reinforcing existing positions rather than prompting new aggressive action, pending further fundamental analysis.
Keywords
Tanger Inc., SKT, Jeffrey B. Citrin, Director, Insider Transaction, Form 4, Deferred Share Units, Equity Compensation, Rule 10b5-1, Dividend Reinvestment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.